Evidence Synthesis
PPLPHARMA's Gross Margin accelerated to 59.42%, up from -1.25%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 15 Sept 2026, 04:00
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
PPLPHARMA's Gross Margin accelerated to 59.42%, up from -1.25%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 59.42 % | -1.25 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -1.25 % | -3.41 | ▲ |
| REVENUE_GROWTH_YOY | 17.4 % | — | - |
| EPS_ACTUAL | -0.75 INR | -0.719 | ▼ |
| EPS_SURPRISE_PERCENT | -1.586 % | -8.588 | ▲ |
| PRICE_CHANGE_PERCENT | -0.466 % | — | - |
| DAILY_VOLUME | 34,08,833 shares | 79,29,819 | ▼ |
| CLOSE_PRICE | 211.5 INR | 212.49 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.82 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 2 count | 8 | ▼ |
| TARGET_PRICE_PREMIUM | 10.29 % | — | - |